- Home
- FTHM vs TPST Comparison
FTHM vs TPST Comparison
Compare FTHM & TPST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FTHM
- TPST
- Stock Information
- Founded
- FTHM 2010
- TPST 2011
- Country
- FTHM United States
- TPST United States
- Employees
- FTHM N/A
- TPST N/A
- Industry
- FTHM Real Estate
- TPST Biotechnology: Pharmaceutical Preparations
- Sector
- FTHM Finance
- TPST Health Care
- Exchange
- FTHM Nasdaq
- TPST Nasdaq
- Market Cap
- FTHM 32.8M
- TPST 27.2M
- IPO Year
- FTHM 2020
- TPST N/A
- Fundamental
- Price
- FTHM $1.43
- TPST $0.93
- Analyst Decision
- FTHM Strong Buy
- TPST Strong Buy
- Analyst Count
- FTHM 4
- TPST 4
- Target Price
- FTHM $4.25
- TPST $20.00
- AVG Volume (30 Days)
- FTHM 75.3K
- TPST 1.8M
- Earning Date
- FTHM 03-13-2025
- TPST 11-12-2024
- Dividend Yield
- FTHM N/A
- TPST N/A
- EPS Growth
- FTHM N/A
- TPST N/A
- EPS
- FTHM N/A
- TPST N/A
- Revenue
- FTHM $317,515,000.00
- TPST N/A
- Revenue This Year
- FTHM N/A
- TPST N/A
- Revenue Next Year
- FTHM $28.50
- TPST N/A
- P/E Ratio
- FTHM N/A
- TPST N/A
- Revenue Growth
- FTHM N/A
- TPST N/A
- 52 Week Low
- FTHM $1.32
- TPST $0.70
- 52 Week High
- FTHM $3.37
- TPST $6.00
- Technical
- Relative Strength Index (RSI)
- FTHM 36.85
- TPST 54.03
- Support Level
- FTHM $1.36
- TPST $0.86
- Resistance Level
- FTHM $1.51
- TPST $1.05
- Average True Range (ATR)
- FTHM 0.12
- TPST 0.08
- MACD
- FTHM 0.01
- TPST 0.01
- Stochastic Oscillator
- FTHM 19.44
- TPST 52.92
About FTHM Fathom Holdings Inc.
Fathom Holdings Inc is a national, technology-driven, real estate services platform integrating residential brokerage, mortgage, title, insurance, and Software as a Service offering to brokerages and agents by leveraging proprietary cloud-based software, intelliAgent. The company has three reportable segments namely Real Estate Brokerage, Mortgage and Technology. The brands of the company include Fathom Realty, Dagley Insurance, Encompass Lending, intelliAgent, LiveBy, Real Results, and Verus Title.
About TPST Tempest Therapeutics Inc.
Tempest Therapeutics Inc is a late-stage develpment biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Its clinical-stage therapeutic product candidates are TPST-1120 and TPST-1495 which are clinical-stage molecules designed to inhibit their respective targets.